Table 3 Effects of exogenous DHA-rich n-3 PUFAs supplementation during the pregnancy on the profiles of PUFAs in the colostrum

37.83 ± 4.92

38.33 ± 5.24

39.14 ± 3.99

39.08 ± 5.41

0.451

4.66 ± 2.89

4.92 ± 2.88

5.70 ± 2.53

6.11 ± 3.87

0.110

4.46 ± 1.68

4.67 ± 1.57

4.57 ± 1.53

4.57 ± 1.68

0.932

23.37 ± 2.30

23.32 ± 2.34

23.46 ± 1.31

22.96 ± 2.09

0.470

5.34 ± 0.77

5.41 ± 0.79

5.39 ± 0.67

5.44 ± 0.91

0.911

38.51 ± 6.79

37.83 ± 8.29

39.02 ± 3.06

37.34 ± 3.92

0.679

2.30 ± 0.69

2.38 ± 0.59

2.41 ± 0.61

2.24 ± 0.67

0.477

36.21 ± 6.91

36.81 ± 4.51

36.61 ± 2.75

35.77 ± 6.30

0.705

22.05 ± 6.29

22.33 ± 5.62

20.18 ± 2.64

22.38 ± 6.80

0.325

21.02 ± 6.79

21.25 ± 6.05

19.00 ± 2.76

21.05 ± 6.73

0.644

0.65 ± 0.15*^#

0.69 ± 0.16*^#

0.76 ± 0.15

0.82 ± 0.11

0.047

0.031 ± 0.0091*^#

0.032 ± 0.0068*^#

0.040 ± 0.0080

0.039 ± 0.0059

0.046

1.98 ± 0.18*^#

1.95 ± 0.17*^#

1.63 ± 0.13

1.69 ± 0.17

0.021

0.23 ± 0.042

0.25 ± 0.069

0.23 ± 0.036

0.23 ± 0.052

0.748

1.31 ± 0.20*^#

1.31 ± 0.18*^#

1.13 ± 0.14

1.12 ± 0.16

0.045

0.44 ± 0.031*^#

0.39 ± 0.021*^#

0.27 ± 0.041

0.34 ± 0.041

0.004

5.70 ± 1.09

5.24 ± 0.81

4.91 ± 0.74

4.87 ± 1.51

0.107

1.91 ± 0.19*^#

1.56 ± 0.14*^#

1.17 ± 0.16

1.27 ± 0.10

0.007

0.34 ± 0.051*^#

0.30 ± 0.045*^#

0.24 ± 0.081

0.25 ± 0.091

0.014

11.14 ± 1.71*^#

11.45 ± 2.01*^#

12.38 ± 1.31

12.25 ± 2.01

0.024